• Discussing optimized experimental PTM enrichment workflows for increased sensitivity and robustness
• Benchmarking novel mass spectrometers and proteomic data processing tools for enhanced coverage of the PTM-ome
• Sharing examples for the application of PTM data to guide decision-making in different stages of the drug discovery process

Speakers:

Ben Ruprecht

Director, Proteomics

Blueprint Medicines